Bi-allelic loss-of-function variants in TMEM147 cause moderate to profound intellectual disability with facial dysmorphism and pseudo-Pelger-Huët anomaly.

DNA methylation LBR Pelger-Huët anomaly TMEM147 facial dysmorphism intellectual disability neurodevelopmental disorder nuclear envelope instability transcriptomics translocon dysfunction

Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
06 10 2022
Historique:
received: 11 06 2022
accepted: 09 08 2022
pubmed: 1 9 2022
medline: 12 10 2022
entrez: 31 8 2022
Statut: ppublish

Résumé

The transmembrane protein TMEM147 has a dual function: first at the nuclear envelope, where it anchors lamin B receptor (LBR) to the inner membrane, and second at the endoplasmic reticulum (ER), where it facilitates the translation of nascent polypeptides within the ribosome-bound TMCO1 translocon complex. Through international data sharing, we identified 23 individuals from 15 unrelated families with bi-allelic TMEM147 loss-of-function variants, including splice-site, nonsense, frameshift, and missense variants. These affected children displayed congruent clinical features including coarse facies, developmental delay, intellectual disability, and behavioral problems. In silico structural analyses predicted disruptive consequences of the identified amino acid substitutions on translocon complex assembly and/or function, and in vitro analyses documented accelerated protein degradation via the autophagy-lysosomal-mediated pathway. Furthermore, TMEM147-deficient cells showed CKAP4 (CLIMP-63) and RTN4 (NOGO) upregulation with a concomitant reorientation of the ER, which was also witnessed in primary fibroblast cell culture. LBR mislocalization and nuclear segmentation was observed in primary fibroblast cells. Abnormal nuclear segmentation and chromatin compaction were also observed in approximately 20% of neutrophils, indicating the presence of a pseudo-Pelger-Huët anomaly. Finally, co-expression analysis revealed significant correlation with neurodevelopmental genes in the brain, further supporting a role of TMEM147 in neurodevelopment. Our findings provide clinical, genetic, and functional evidence that bi-allelic loss-of-function variants in TMEM147 cause syndromic intellectual disability due to ER-translocon and nuclear organization dysfunction.

Identifiants

pubmed: 36044892
pii: S0002-9297(22)00360-3
doi: 10.1016/j.ajhg.2022.08.008
pmc: PMC9606387
pii:
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1909-1922

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests S.A., I.K., J.P.B., and A.B.-A. are employees of Centogene GmbH.

Références

Nat Genet. 2002 Aug;31(4):410-4
pubmed: 12118250
EMBO J. 1998 Nov 2;17(21):6168-77
pubmed: 9799226
Hum Genet. 2017 Nov;136(11-12):1419-1429
pubmed: 28940097
J Cell Sci. 2020 Aug 21;133(16):
pubmed: 32694168
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Am J Med Genet A. 2013 Aug;161A(8):2066-73
pubmed: 23824842
Am J Hum Genet. 2021 Mar 4;108(3):502-516
pubmed: 33596411
J Cell Biol. 2001 Jun 11;153(6):1287-300
pubmed: 11402071
Eur J Hum Genet. 2013 Oct;21(10):1100-4
pubmed: 23403903
J Cell Sci. 1998 May;111 ( Pt 10):1441-51
pubmed: 9570761
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
Cell. 2006 Feb 10;124(3):573-86
pubmed: 16469703
Am J Hum Genet. 2016 Jul 7;99(1):174-87
pubmed: 27392076
Pediatr Gastroenterol Hepatol Nutr. 2021 Jan;24(1):1-6
pubmed: 33505888
Bioinformatics. 2021 Jul 16;:
pubmed: 34270679
Cell Rep. 2015 Jan 13;10(2):148-61
pubmed: 25558065
Am J Intellect Dev Disabil. 2021 Nov 1;126(6):439-442
pubmed: 34700345
Trends Biochem Sci. 1998 Jun;23(6):198-9
pubmed: 9644970
Am J Med. 1971 Mar;50(3):302-12
pubmed: 5553949
Mol Biol Cell. 2005 Apr;16(4):1928-37
pubmed: 15703217
Cell. 2013 Jan 31;152(3):584-98
pubmed: 23374351
Am J Med Genet. 1988 Mar;29(3):623-32
pubmed: 3377005
Nat Genet. 2019 Nov;51(11):1645-1651
pubmed: 31659324
J Biol Chem. 2010 Aug 20;285(34):26174-81
pubmed: 20538592
Elife. 2020 Aug 21;9:
pubmed: 32820719
Front Neurosci. 2021 Nov 05;15:774950
pubmed: 34803598
J Cell Sci. 1993 Mar;104 ( Pt 3):671-83
pubmed: 8314869
IUBMB Life. 2000 Jul;50(1):1-11
pubmed: 11087114
J Cell Biol. 1994 Jul;126(1):25-39
pubmed: 8027183
Development. 2007 Mar;134(6):1023-34
pubmed: 17287255
Commun Biol. 2021 Apr 12;4(1):478
pubmed: 33846535
Hum Mutat. 2019 Aug;40(8):1030-1038
pubmed: 31116477
J Biol Chem. 2007 Apr 6;282(14):10632-8
pubmed: 17261586
Clin Genet. 2013 Oct;84(4):394-5
pubmed: 23320496
Genesis. 2014 Jun;52(6):458-70
pubmed: 24510729
Sci Transl Med. 2011 Jun 22;3(88):88ra55
pubmed: 21697531
Mol Pharmacol. 2011 Feb;79(2):251-61
pubmed: 21056967
EMBO J. 2004 Aug 4;23(15):3041-50
pubmed: 15257293
Genome Res. 2005 Jul;15(7):901-13
pubmed: 15965027
Nature. 2015 Mar 12;519(7542):223-8
pubmed: 25533962
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Elife. 2014 Jun 24;3:e02020
pubmed: 24963138
Am J Hum Genet. 2016 Oct 6;99(4):877-885
pubmed: 27666373
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Am J Hum Genet. 2018 Nov 1;103(5):794-807
pubmed: 30401460
EMBO J. 1996 Dec 16;15(24):7108-19
pubmed: 9003786
Am J Med Genet A. 2019 Jul;179(7):1338-1345
pubmed: 31102500
Am J Med Genet A. 2015 Jan;167A(1):159-63
pubmed: 25348816
Annu Rev Genomics Hum Genet. 2013;14:355-69
pubmed: 23875798
Prog Pediatr Cardiol. 2015 Jul 1;39(1):13-19
pubmed: 26380542
Int J Mol Sci. 2021 Sep 23;22(19):
pubmed: 34638576
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):258-63
pubmed: 20018682
Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):895-900
pubmed: 9023353
Nat Commun. 2018 Apr 10;9(1):1366
pubmed: 29636450

Auteurs

Quentin Thomas (Q)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France. Electronic address: quentin.thomas@chu-dijon.fr.

Marialetizia Motta (M)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.

Thierry Gautier (T)

University Grenoble Alpes, Inserm, CNRS, Institute for Advanced Biosciences, 38000 Grenoble, France.

Maha S Zaki (MS)

Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt; Armed Forces College of Medicine, Cairo, Egypt.

Andrea Ciolfi (A)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.

Julien Paccaud (J)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.

François Girodon (F)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France; Biology Division, Department of Biological Hematology, Dijon Hospital, 21000 Dijon, France.

Odile Boespflug-Tanguy (O)

Université Paris Cité, UMR 1141 NeuroDiderot, Inserm, 75019 Paris, France; Service de Neuropédiatrie, reference center for leukodystrophies, APHP, Hopital Robert Debré, 75019 Paris, France.

Thomas Besnard (T)

Service de Génétique Médicale, CHU Nantes, Nantes, France; Université de Nantes, CHU Nantes, CNRS, Inserm, l'Institut du Thorax, 44000 Nantes, France.

Jennifer Kerkhof (J)

Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada.

Haley McConkey (H)

Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada; Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.

Aymeric Masson (A)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.

Anne-Sophie Denommé-Pichon (AS)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France; Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Benjamin Cogné (B)

Service de Génétique Médicale, CHU Nantes, Nantes, France; Université de Nantes, CHU Nantes, CNRS, Inserm, l'Institut du Thorax, 44000 Nantes, France.

Eva Trochu (E)

Service de Génétique Médicale, CHU Nantes, Nantes, France.

Virginie Vignard (V)

Université de Nantes, CHU Nantes, CNRS, Inserm, l'Institut du Thorax, 44000 Nantes, France.

Fatima El It (F)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.

Lance H Rodan (LH)

Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Mohammad Ayman Alkhateeb (MA)

Women Wellness and Research Center Hamad Medical Corporation, Doha, Qatar.

Rami Abou Jamra (RA)

Institute of Human Genetics, University Medical Center, Leipzig, Germany.

Laurence Duplomb (L)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.

Emilie Tisserant (E)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.

Yannis Duffourd (Y)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.

Ange-Line Bruel (AL)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France; Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Adam Jackson (A)

Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.

Siddharth Banka (S)

Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.

Meriel McEntagart (M)

Medical Genetics, St George's University Hospitals NHS FT, London SW17 0RE, UK.

Anand Saggar (A)

Medical Genetics, St George's University Hospitals NHS FT, London SW17 0RE, UK; The Portland Hospital, 205-209 Great Portland St, London W1W 5AH, UK.

Joseph G Gleeson (JG)

Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA; Rady Children's Institute for Genomic Medicine, San Diego, La Jolla, CA 92093, USA.

David Sievert (D)

Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.

Hyunwoo Bae (H)

Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Beom Hee Lee (BH)

Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Kisang Kwon (K)

3billion, Inc, Seoul, South Korea.

Go Hun Seo (GH)

3billion, Inc, Seoul, South Korea.

Hane Lee (H)

3billion, Inc, Seoul, South Korea.

Anjum Saeed (A)

Children's Hospital and University of Child Health Lahore, Lahore, Pakistan.

Nadeem Anjum (N)

Children's Hospital and University of Child Health Lahore, Lahore, Pakistan.

Huma Cheema (H)

Children's Hospital and University of Child Health Lahore, Lahore, Pakistan.

Salem Alawbathani (S)

CENTOGENE GmbH, 18055 Rostock, Germany.

Imran Khan (I)

CENTOGENE GmbH, 18055 Rostock, Germany.

Jorge Pinto-Basto (J)

CENTOGENE GmbH, 18055 Rostock, Germany.

Joyce Teoh (J)

Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore, A(∗)STAR, Singapore, Singapore.

Jasmine Wong (J)

Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore, A(∗)STAR, Singapore, Singapore.

Umar Bin Mohamad Sahari (UBM)

Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore, A(∗)STAR, Singapore, Singapore.

Henry Houlden (H)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.

Kristina Zhelcheska (K)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.

Melanie Pannetier (M)

Service d'Hématologie cellulaire et hémostase bioclinique, CHU Rennes, Rennes, France.

Mona A Awad (MA)

Clinical and Chemical Pathology Department, Medical Research and Clinical Studies Institute National Research Centre, Cairo, Egypt.

Marion Lesieur-Sebellin (M)

Service de Médecine Génomique des Maladies Rares, Hôpital Necker-Enfant Malades, AP-HP, Paris, France.

Giulia Barcia (G)

Service de Médecine Génomique des Maladies Rares, Hôpital Necker-Enfant Malades, AP-HP, Paris, France.

Jeanne Amiel (J)

Service de Médecine Génomique des Maladies Rares, Hôpital Necker-Enfant Malades, AP-HP, Paris, France.

Julian Delanne (J)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France; Centre de Référence maladies rares « Anomalies du Développement et syndromes malformatifs », Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Christophe Philippe (C)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France; Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Laurence Faivre (L)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France; Centre de Référence maladies rares « Anomalies du Développement et syndromes malformatifs », Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Sylvie Odent (S)

Service de Génétique Clinique, Centre Référence Anomalies du Développement CLAD Ouest, Univ Rennes, Rennes, France; Institut de Génétique et Développement de Rennes, CNRS Inserm UMR 6290, ERL 1305, Univ Rennes, Rennes, France.

Aida Bertoli-Avella (A)

CENTOGENE GmbH, 18055 Rostock, Germany.

Christel Thauvin (C)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France; Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France; Centre de référence maladies rares « déficiences intellectuelles de causes rares », Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Bekim Sadikovic (B)

Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada; Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.

Bruno Reversade (B)

Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore, A(∗)STAR, Singapore, Singapore; Medical Genetics Department, School of Medicine, Koç University, Istanbul, Turkey; Smart-Health Initiative, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia.

Reza Maroofian (R)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.

Jérôme Govin (J)

University Grenoble Alpes, Inserm, CNRS, Institute for Advanced Biosciences, 38000 Grenoble, France.

Marco Tartaglia (M)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.

Antonio Vitobello (A)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France; Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France. Electronic address: antonio.vitobello@u-bourgogne.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH